IXP Lifesciences Catalyst Fund (IXP)

Check the fit first

• IXP is a Lifesciences-only investor. It lists Biopharma, Medical Technology, Nutraceuticals, Cosmeceuticals and Speciality Chemicals, plus allied areas.
• Its stated stage range is Pre-seed to Series A.
• Companies from overseas are in scope if they are expanding R&D in India.

How to approach

• Fill in the application form on the IXP website. It asks about you and the business you are working on, and IXP says it will get back to you.
• You can also write to connect@ixplifesciences.com and pick the Seeking Investments option on the contact page.
• Lifesciences professionals with a B2B idea and at least a decade of industry experience can write to portfolio@ixplifesciences.com about the Venture Studio. That route is open all year round.

Before you write

• Say clearly what unmet need you address and why the business is commercially viable.
• Be ready to explain your lab and R&D needs. The group offers lab access and a contract research arm, so a plan that uses them will be easy to discuss.
• The site gives no deadlines, cheque sizes or review timeline, so do not expect a fixed process.

IXP Lifesciences Catalyst Fund, known as IXP, is a venture capital fund for Lifesciences start-ups, based in Nanakaramguda, Hyderabad. IXP stands for Innovation Acceleration Platform, and the fund is part of the JV Ventures group. It describes itself as a Category I alternative investment fund (venture capital fund, angel fund) and says it is more than an investment platform: it wants to be a success enabler for biotechs.

IXP invests in start-ups from Pre-seed to Series A. The sector focus is broad: Biopharma, Medical Technology, Nutraceuticals, Cosmeceuticals, Speciality Chemicals and allied areas, with a stated aim of improving human health. The India angle is central to its thesis. It backs home grown start-ups and also companies overseas that want to expand their R&D footprint in India.

What founders get besides capital

IXP says it acts as a strategic partner, not a cookie-cutter investor, and that its evaluation is steered by Lifesciences industry veterans. Portfolio companies can draw on a group ecosystem it calls PoweRx. Through Rx Propellant, a Lifesciences infrastructure platform, they can get access to compliant R&D labs in key clusters across India. GVRP is an in-house CRO for chemistry and biology services and for setting up a dedicated centre of excellence, which lets start-ups keep operations lean. GV Connect is a non-profit networking platform for the scientific community.

IXP Venture Studio

Separately from the fund, IXP Venture Studio co-creates new companies with scientists and professionals through its Venturepreneur Program. IXP takes a hands-on role in ideation, creation and early-stage development. Founders in the studio get access to seed funding, mentors and operational expertise. The studio is open to applications from professionals all year round if they have at least a decade of Lifesciences industry experience, a B2B idea (products or services) and a clear market need with commercial viability.

How to reach IXP

The website has an application form where you describe yourself and your business, and says IXP will get back to you. The contact page lists a Seeking Investments enquiry type, and the general inbox is connect@ixplifesciences.com. Venture Studio enquiries go to portfolio@ixplifesciences.com. The office is at One West Terminus, Nanakaramguda, Financial District, Hyderabad 500008. The site does not publish a ticket size or a selection timeline.